FDA approves Alexion’s Ultomiris for another rare blood disease
(Reuters) – The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc’s treatment for a second rare blood…
Patent court to review Alexion’s Soliris patents on Amgen challenge
(Reuters) – The U.S. patent office will review patents on Alexion Pharmaceuticals Inc’s blood disorder treatment Soliris, after Amgen Inc…
U.S. FDA approves Alexion Pharma’s blood disorder drug
(Reuters) – The U.S. Food and Drug Administration has approved Alexion Pharmaceuticals Inc’s blood disorder drug Ultomiris, the pharma regulator’s…
Biotech M&A rolls on as Alex ion snaps up Wilson for $855 mln
(Reuters) – Alex ion Pharmaceuticals has agreed to buy Sweden’s Wilson Therapeutics for 7.1 billion Swedish crowns ($855 million), boosting…